The eLife online journal has published its first “computationally reproducible” article, where figures are integrated with the software, data and computational environment required to produce them.
D4: Pharma is a highly-select gathering of 80-100 very senior and experienced pharma professionals responsible for making important decisions, as well as turning innovation and new ideas into measurable progress.
Genomics England, NHS England and The Royal Society are holding a scientific meeting at the Royal Society in Carlton House Terrace to celebrate the successful conclusion of the 100,000 Genomes Project, which was declared finished in December last year.
While the Annual Meeting & Expo is the pinnacle of the association’s educational calendar, AMP offers educational initiatives throughout the year in a variety of formats, many of which offer continuing education credit.
New research from Indiana University has identified “hotspots” in DNA where the risk for genetic mutations is significantly elevated.
A small population of brain cells deep in a memory-making region of the brain controls the production of new neurons and may have a role in common brain disorders.
Americans are more likely to anticipate negative than positive effects from widespread use of gene-editing technology.
Although primarily influenced by environmental and social factors, years of schooling are also influenced by genes associated with cognitive function such as memory and personality traits.
US representatives are pressing genetic testing companies for details on their security systems and customer privacy policies.
Scientists have mapped 41 genes that increase the risk of developing hay fever, in a new study of almost 900,000 people. Of the genes, 20 are new to science.